You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

EXEMESTANE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Exemestane patents expire, and what generic alternatives are available?

Exemestane is a drug marketed by Alvogen, Amneal Pharms, Breckenridge, Cipla, Dr Reddys Labs Sa, Eugia Pharma, Hikma, Qilu, Rising, Upsher Smith Labs, and Zydus Pharms. and is included in eleven NDAs.

The generic ingredient in EXEMESTANE is exemestane. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the exemestane profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Exemestane

A generic version of EXEMESTANE was approved as exemestane by HIKMA on April 1st, 2011.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EXEMESTANE?
  • What are the global sales for EXEMESTANE?
  • What is Average Wholesale Price for EXEMESTANE?
Summary for EXEMESTANE
Drug patent expirations by year for EXEMESTANE
Drug Prices for EXEMESTANE

See drug prices for EXEMESTANE

Recent Clinical Trials for EXEMESTANE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Breast Cancer Research FoundationPhase 2
QuantumLeap Healthcare CollaborativePhase 2
NRG OncologyPhase 2

See all EXEMESTANE clinical trials

Pharmacology for EXEMESTANE
Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors

US Patents and Regulatory Information for EXEMESTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen EXEMESTANE exemestane TABLET;ORAL 200898-001 Jul 28, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma EXEMESTANE exemestane TABLET;ORAL 077431-001 Apr 1, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cipla EXEMESTANE exemestane TABLET;ORAL 210323-001 Apr 27, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Qilu EXEMESTANE exemestane TABLET;ORAL 213547-001 Apr 13, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.